Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murali Ragothaman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Vaccines|May 27, 2023
Engineered Phage-Based Cancer Vaccines: Current Advances and Future DirectionsMurali Ragothaman, So Young Yoo
Carbohydrate Polymers|September 30, 2014
Collagen-poly(dialdehyde) guar gum based porous 3D scaffolds immobilized with growth factor for tissue engineering applicationsMurali Ragothaman, Thanikaivelan Palanisamy, Cheirmadurai Kalirajan
ACS Omega|August 29, 2019
Bifunctional Hybrid Composites from Collagen Biowastes for Heterogeneous ApplicationsBerhanu Telay Mekonnen, Murali Ragothaman, Thanikaivelan Palanisamy
Materials Science & Engineering. C, Materials for Biological Applications|September 3, 2021
Bio-hybrid hydrogel comprising collagen-capped silver nanoparticles and melatonin for accelerated tissue regeneration in skin defectsMurali Ragothaman, Arivizhivendhan Kannan Villalan, Anuradha Dhanasekaran, et al.
Pharmaceutics|February 25, 2023
Recent Advances in Cancer Immunotherapy Delivery ModalitiesPalaniyandi Muthukutty, Hyun Young Woo, Murali Ragothaman, et al.
Journal of Materials Chemistry. B|September 20, 2024
<i>In vivo</i> safety evaluation and tracing of arginylglycylaspartic acid-engineered phage nanofiber in murine modelKshitiz Raj Shrestha, Sehoon Kim, Anna Jo, et al.
Extracellular Vesicles and Circulating Nucleic Acids|January 19, 2026
Tumor-targeted multifunctional extracellular vesicles as drug carriers for lung cancer therapyNarsireddy Amreddy, Akhil Srivastava, Natascha Riedinger, et al.
Cancers|January 10, 2026
BRG1 (SMARCA4) Status Dictates the Response to EGFR Inhibitors in Wild-Type EGFR Non-Small Cell Lung CancerRebaz Ahmed, Ranganayaki Muralidharan, Narsireddy Amreddy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vaccines|May 27, 2023
Engineered Phage-Based Cancer Vaccines: Current Advances and Future DirectionsMurali Ragothaman, So Young Yoo
Carbohydrate Polymers|September 30, 2014
Collagen-poly(dialdehyde) guar gum based porous 3D scaffolds immobilized with growth factor for tissue engineering applicationsMurali Ragothaman, Thanikaivelan Palanisamy, Cheirmadurai Kalirajan
ACS Omega|August 29, 2019
Bifunctional Hybrid Composites from Collagen Biowastes for Heterogeneous ApplicationsBerhanu Telay Mekonnen, Murali Ragothaman, Thanikaivelan Palanisamy
Materials Science & Engineering. C, Materials for Biological Applications|September 3, 2021
Bio-hybrid hydrogel comprising collagen-capped silver nanoparticles and melatonin for accelerated tissue regeneration in skin defectsMurali Ragothaman, Arivizhivendhan Kannan Villalan, Anuradha Dhanasekaran, et al.
Pharmaceutics|February 25, 2023
Recent Advances in Cancer Immunotherapy Delivery ModalitiesPalaniyandi Muthukutty, Hyun Young Woo, Murali Ragothaman, et al.
Journal of Materials Chemistry. B|September 20, 2024
<i>In vivo</i> safety evaluation and tracing of arginylglycylaspartic acid-engineered phage nanofiber in murine modelKshitiz Raj Shrestha, Sehoon Kim, Anna Jo, et al.
Extracellular Vesicles and Circulating Nucleic Acids|January 19, 2026
Tumor-targeted multifunctional extracellular vesicles as drug carriers for lung cancer therapyNarsireddy Amreddy, Akhil Srivastava, Natascha Riedinger, et al.
Cancers|January 10, 2026
BRG1 (SMARCA4) Status Dictates the Response to EGFR Inhibitors in Wild-Type EGFR Non-Small Cell Lung CancerRebaz Ahmed, Ranganayaki Muralidharan, Narsireddy Amreddy, et al.
Pageof 1